Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on: December 18,2023

Biomarker blood test confirms remission in patients with HPV+ oral cancer

byAmerican Society for Radiation OncologyA highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related

Updated on:December 18,2023

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on: January 07,2024

Exploring the biology of 'double positive' T cells

byLudwig Cancer ResearchCredit: CC0 Public DomainThe molecular markers CD4 and CD8—defining helper T cells and killer T cells, respectively—were once considered mutually exclusive. But "dou

Updated on:January 07,2024

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t

Updated on: December 23,2023

National prostate cancer trial currently testing therapy based on molecular discovery

byCleveland ClinicCredit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI163498A new prostate cancer therapy in clinical trials could treat patients resistant to treatment t

Updated on:December 23,2023

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on: March 30,2024

ASCO endorses SIO guideline for integrative Tx in breast cancer

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treat

Updated on:March 30,2024

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on: December 22,2023

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on:December 22,2023

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on: June 01,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on:June 01,2024

Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

byWileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many

Updated on: December 22,2023

Defensive beliefs likely keep people from taking at-home stool tests that screen for colorectal cancer

byWileyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many

Updated on:December 22,2023

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on: January 10,2024

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on:January 10,2024

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on: December 22,2023

Metabolic adaptation ensures survival of colon cancer cells

byGerman Cancer Research CenterCredit: CC0 Public DomainColon cancer cells deficient in p53, one of the most important control proteins in cell growth, activate a particular metabolic pathway to

Updated on:December 22,2023

Cellular senescence plays a significant role in cerebral tumors

by Marie Simon,Paris Brain InstituteCells derived from a murine glioblastoma model and embedded in a 3D extracellular matrix. Confocal microscope. Credit: Isabelle Le Roux.Glioblastomas are the

Updated on: January 10,2024

Cellular senescence plays a significant role in cerebral tumors

by Marie Simon,Paris Brain InstituteCells derived from a murine glioblastoma model and embedded in a 3D extracellular matrix. Confocal microscope. Credit: Isabelle Le Roux.Glioblastomas are the

Updated on:January 10,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on: February 20,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on:February 20,2024

What are 'cancer vaccines,' and what similarities do they share with COVID vaccines?

by Sathana Dushyanthen,The ConversationCredit: AI-generated imageBarely a month goes by without headlines announcing yet another advancement in cancer vaccines.Just last month, the United States

Updated on: January 04,2024

What are 'cancer vaccines,' and what similarities do they share with COVID vaccines?

by Sathana Dushyanthen,The ConversationCredit: AI-generated imageBarely a month goes by without headlines announcing yet another advancement in cancer vaccines.Just last month, the United States

Updated on:January 04,2024